posted by:
Wendy Blackburn
at 9:00 AM
March 30, 2012
Today is “d-day” for some pharma companies deciding what to do with their Facebook pages, as Facebook forces all Pages to adopt its new Timeline layout. (Read our “7 Things Pharma Should Know About Facebook Timeline” for more info.) Facebook’s non-optional switch to Timeline is just another reminder ...
posted by:
Wendy Blackburn
at 1:00 PM
March 15, 2012
In case you missed it, industry organization Digital Health Coalition (DHC) (on the Web here and on Facebook ) recently published self-imposed guidelines for how pharmaceutical companies should engage in social media (full disclosure: I am a “Digital Health Scholar” for the DHC, though I can’t take ...
posted by:
Wendy W. Blackburn
at 9:00 AM
January 26, 2012
Introduction On January 24 FDA issued new, final guidance on “product name placement, size, and prominence in advertising and promotional labeling.” I can tell you up front this still isn't the long-awaited social media guidance. Instead, the document sets out to clarify FDA requirements and expectations for how and when ...
posted by:
Wendy Blackburn
at 1:00 PM
January 18, 2012
This topic comes up a lot around my agency: How do you define DTC? Of course, on the surface, DTC in the context of pharma marketing stands for "direct-to-consumer." Its roots likely go back to when FDA first approved the marketing of prescription products to U.S.consumers in the 1980's....
posted by:
Wendy W. Blackburn
at 2:00 PM
December 21, 2011
My husband and I went on an overseas trip over the Thanksgiving holiday. For the first time in our lives, we stayed at what was ranked the #1 hotel by TripAdvisor. We typically would not stay at a top-of-the-list (nor top-of-the-price-range) hotel, but we booked last-minute with the intention ...